IL-17 secreted by γδ T cells may directly act on CD4+ T cells, since in vitro stimulation with Fulvestrant molecular weight IL-17A and IL-23 upregulates IL-17A/F mRNA expression in CD4+ T cells 37, or indirectly, by conditioning resident APCs. Moreover, this early IL-17 production may also act directly on APCs, such as macrophages and subsets of DCs, which are known to express IL-17R more abundantly than T cells, and provoke APC

production of IL-23, IL-1, IL-6 and TGF-β1 37, 55, which are crucial factors for pathogenic Th17-cell development. Consistently, IL-17 secretion is significantly more elevated in mucosal tissues, where we detected an elevated level of IL-1β and IL-6 mRNA expression. Importantly, our results show that CD4+CD25+Foxp3+ TREG cells directly suppress the proliferation and differentiation of γδ T cells in vitro and in vivo. Moreover, we show that in the context of mucosal inflammation, TREG cells restrain the proliferation of resident γδ T cells more strongly than donor CD4+CD25− TEFF cells, although a similar potency in TREG cell-mediated suppression of both populations is observed in vitro. This finding is consistent with a recent study showing that TREG cells inhibit γδ T-cell proliferation in vitro 32, 40. It is possible that the more potent TREG-cell suppression

of IL-17 secretion compared with IFN-γ secretion seen in the mucosal tissue occurs as a result of a more profound inhibition of γδ T-cell expansion in situ. Whether this happens due to a greater susceptibility of γδ T cells to direct TREG cell-mediated this website suppression or indirect inhibition mediated by TREG cell-conditioned APCs requires further investigation. Interestingly, in contrast to γδ T cells, a significant fraction (around 30%) of CD4+ TEFF cells found in mucosa-associated tissues co-expressed Anidulafungin (LY303366) IFN-γ and IL-17, an observation reminiscent of recent human studies showing the existence of IFN-γ/IL-17 dual producing CD4+ T cells in colonic biopsies of CD patients 25. Furthermore, our results

demonstrate that both CD4+ and γδ T cells from mucosal tissues of recipient mice are more activated as they display a higher proliferation rate and secrete more pro-inflammatory cytokines compared to cells from LNs. Although TREG cells are not able to completely inhibit priming of the pro-inflammatory TEFF cells in the mucosa-draining lymphoid tissues (mesLN), the dramatic reduction in absolute numbers of LP-infiltrating lymphocytes suggests that TREG cells regulate the influx and/or expansion of activated αβ and γδ TEFF-cell subsets in the site of tissue inflammation. These results are consistent with a recent study by Park et al., which identifies IL-10 as a potential mediator in Foxp3+ TREG cell-mediated suppression of γδ T cells 32.